TCIM
FSTX

TIAA CREF Investment Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

TIAA CREF Investment Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$162K Sell
3,852
-14
-0.4% -$590 ﹤0.01% 2912
2018
Q4 		$161K Sell
3,866
-158
-4% -$7.11K ﹤0.01% 2913
2018
Q3 		$194K Sell
4,024
-233
-5% -$11.7K ﹤0.01% 2988
2018
Q2 		$202K Buy
+4,257
New +$236K ﹤0.01% 3034

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

TIAA CREF Investment Management's FSTX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its F-star Therapeutics, Inc. Common Stock (FSTX) stake by 0.36% in Q1 2019, selling an estimated $590 and leaving 3,852 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

TIAA CREF Investment Management first reported a position in FSTX in Q2 2018 and has held it in 4 quarters since. The position peaked at $202K in Q2 2018. 54 funds tracked by Wall St. Rank hold FSTX as of Q1 2019.

  • TIAA CREF Investment Management held 3,852 shares of F-star Therapeutics, Inc. Common Stock worth $162K as of Q1 2019.
  • TIAA CREF Investment Management sold 14 F-star Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $590.
  • F-star Therapeutics, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2912 holding.
  • TIAA CREF Investment Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's F-star Therapeutics, Inc. Common Stock position peaked at $202K in Q2 2018.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.